全文获取类型
收费全文 | 1710篇 |
免费 | 200篇 |
国内免费 | 14篇 |
专业分类
耳鼻咽喉 | 15篇 |
儿科学 | 46篇 |
妇产科学 | 29篇 |
基础医学 | 263篇 |
口腔科学 | 21篇 |
临床医学 | 252篇 |
内科学 | 329篇 |
皮肤病学 | 21篇 |
神经病学 | 97篇 |
特种医学 | 60篇 |
外科学 | 219篇 |
综合类 | 89篇 |
一般理论 | 4篇 |
预防医学 | 178篇 |
眼科学 | 30篇 |
药学 | 129篇 |
中国医学 | 3篇 |
肿瘤学 | 139篇 |
出版年
2022年 | 14篇 |
2021年 | 15篇 |
2019年 | 25篇 |
2018年 | 24篇 |
2017年 | 16篇 |
2016年 | 15篇 |
2015年 | 22篇 |
2014年 | 17篇 |
2013年 | 46篇 |
2012年 | 47篇 |
2011年 | 59篇 |
2010年 | 58篇 |
2009年 | 37篇 |
2008年 | 50篇 |
2007年 | 56篇 |
2006年 | 57篇 |
2005年 | 55篇 |
2004年 | 68篇 |
2003年 | 73篇 |
2002年 | 51篇 |
2001年 | 61篇 |
2000年 | 54篇 |
1999年 | 67篇 |
1998年 | 27篇 |
1997年 | 28篇 |
1996年 | 30篇 |
1995年 | 24篇 |
1994年 | 16篇 |
1993年 | 22篇 |
1992年 | 48篇 |
1991年 | 46篇 |
1990年 | 47篇 |
1989年 | 44篇 |
1988年 | 37篇 |
1987年 | 33篇 |
1986年 | 51篇 |
1985年 | 45篇 |
1984年 | 43篇 |
1983年 | 31篇 |
1982年 | 28篇 |
1981年 | 21篇 |
1980年 | 20篇 |
1979年 | 31篇 |
1978年 | 15篇 |
1977年 | 26篇 |
1976年 | 27篇 |
1974年 | 17篇 |
1973年 | 17篇 |
1972年 | 20篇 |
1970年 | 17篇 |
排序方式: 共有1924条查询结果,搜索用时 15 毫秒
1.
Although bladder function is thought to be unaffected in Duchenne muscular dystrophy, 46/88 boys interviewed had urinary problems. Nine underwent video urodynamics, showing in eight a small capacity, hyperreflexic bladder, and in the ninth (post spinal surgery) hyperreflexia and detrusor sphincter dyssynergia. Urinary dysfunction is a treatable feature of DMD. 相似文献
2.
JAK2 V617F tyrosine kinase mutation in cell lines derived from myeloproliferative disorders. 总被引:4,自引:0,他引:4
A mutation in the JH2 pseudokinase domain of the Janus kinase 2 gene (JAK2 V617F) has been described in chronic myeloproliferative disorders (MPD). We screened 79 acute myeloid leukemia (AML) cell lines and found five positive for JAK2 V617F (HEL, MB-02, MUTZ-8, SET-2, UKE-1), 4/5 with histories of MPD/MDS. While SET-2 expressed both mutant (mu) and wild-type (wt) JAK2, remaining positives carried homo-/hemizygous JAK2 mutations. Microsatellite analysis confirmed losses of heterozygosity (LOH) affecting the JAK2 region on chromosome 9p in MB-02, MUTZ-8 and UKE-1, but also in HEL, the only JAK2mu cell line lacking any reported MPD/MDS history. All five JAK2mu cell lines displayed cytogenetic hallmarks of MDS, namely losses of 5q or 7q, remarkably in 4/5 cases affecting both chromosomes. Our combined FISH and microsatellite analysis uncovered a novel mechanism to supplement mitotic recombination previously proposed to explain JAK2 LOH, namely chromosome deletion with/without selective JAK2mu amplification. Confirming the importance of the mutated JAK2 protein for growth and prevention of apoptosis, JAK2mu cell lines displayed higher sensitivities to JAK2 inhibition than JAK2wt cell lines. In summary, JAK2 V617F cell lines, derived from patients with history of MPD/MDS, represent novel research tools for elucidating the pathobiology of this JAK2 mutation. 相似文献
3.
4.
A study was undertaken to determine the adequacy of vascularised jejunum to provide stable mucosal cover over a non-biological mandibular substitute. Employing a canine model, composite intra-oral bone-mucosal defects were created and reconstructed with a metal plate covered by a microvascular jejunal patch. These were followed for six months and were assessed clinically, histologically and radiologically. Rapid mucosal healing occurred in all cases. The autografts conformed to the contour of the prosthesis and adequate tongue mobility was preserved. All mandibles remained stable throughout the follow-up period. Histologically, short villi covered the jejunal grafts to three months whilst at six months both normal and abnormal jejunal mucosal morphology was evident. 相似文献
5.
6.
7.
8.
Bernard A. MacLeod Roy McGroarty Roy H. Morton Michael J. A. Walker 《Journal canadien d'anesthésie》1989,36(3):289-294
The effect of halothane on arrhythmias induced by ischaemia was investigated in rats, isolated perfused rat hearts, and pigs. Responses to the occlusion of the left anterior descending coronary artery were determined in groups (n = 9) of chronically prepared rats treated with no halothane, 0.5, or 1.0 per cent halothane immediately after occlusion; in isolated rat hearts (n = 10) treated with no halothane, 0.5, 1.0, 2.0, or 4.0 per cent halothane for 15 min before and after occlusion; and 20–25 kg pigs (n = 11) anaesthetised with halothane or pentobarbital. The ECG, arrhythmias, blood pressure (BP), heart rate (HR) and extent of infarction were determined in each model. In pigs, left ventricular pressure, dp/dtmax and cardiac output were also measured. In chronically prepared rats, halothane anaesthesia started after occlusion was antiarrhythmic and decreased the incidence of ventricular fibrillation and resulting mortality. In isolated rat hearts, 0.5 or 1.0 per cent halothane had little effect on occlusion-induced arrhythmias. The highest concentration of halothane increased the incidence of ventricular fibrillation both before and after occlusion. Halothane decreased developed ventricular pressure in a dose-dependent manner. In acutely prepared pigs, halothane pre-treatment had no appreciable effect upon occlusion-induced arrhythmias when compared with pentobarbital anaesthesia. Thus, halothane is antiarrhythmic when treatment is initiated after occlusion in the rat but this action is not seen in isolated hearts or intact pigs. The antiarrhythmic action of halothane is, therefore, species and model dependent. 相似文献
9.
10.
Effect of inhaled corticosteroids on symptom severity and sputum mediator levels in chronic persistent cough 总被引:6,自引:0,他引:6
Chaudhuri R McMahon AD Thomson LJ MacLeod KJ McSharry CP Livingston E McKay A Thomson NC 《The Journal of allergy and clinical immunology》2004,113(6):1063-1070
BACKGROUND: Chronic cough often lasts for more than 1 year and is associated with airway inflammation. The effect of inhaled corticosteroids on symptom severity and inflammatory mediator levels in these patients is unknown. OBJECTIVE: We sought to determine whether inhaled corticosteroids reduce cough severity and sputum mediator concentrations in patients with chronic persistent cough. METHODS: We performed a double-blind, randomized, placebo-controlled crossover study with inhaled fluticasone, 500 microg twice daily, and placebo for 14 days in 88 patients with cough for more than 1 year, with normal chest radiography and spirometry results. Outcome measures were a daily cough visual analogue scale and induced sputum concentrations of eosinophilic cationic protein (ECP), myeloperoxidase, leukotriene B(4) (LTB(4)), leukotrienes C(4)/D(4)/E(4) (cysteinyl leukotrienes [Cys-LTs]), prostaglandin E(2) (PGE(2)), IL-8, and TNF-alpha. Sputum cell counts, exhaled nitric oxide levels, and carbon monoxide levels were also measured. RESULTS: There was a significant improvement in the cough visual analogue scale after inhaled fluticasone compared with placebo (mean difference, 1.0; 95% CI, 0.4-1.5; P <.001). LTB(4), Cys-LT, and PGE(2) levels were increased in all causes of cough. Sputum ECP counts, exhaled nitric oxide levels, and carbon monoxide levels decreased significantly after inhaled fluticasone. There was no change in sputum cell counts and other mediator concentrations. CONCLUSION: Cough severity and sputum ECP levels are modestly reduced by inhaled corticosteroids in patients with chronic cough persisting for more than 1 year. LTB(4), Cys-LT, PGE(2), IL-8, myeloperoxidase, and TNF-alpha levels are unaltered by this therapy. This raises the possibility that drugs targeted to reduce the effects of these mediators might be of benefit in chronic persistent cough. 相似文献